Supplementary Tables – Long-term safety and efficacy of bisphosphonate therapy in advanced lung cancer with bone metastasis

<strong>Supplementary Table   1</strong> - Safety and efficacy of bisphosphonate therapy
Characteristics of   patients in the PSM dataset. AE-free   survivals of patients with two BP treatment patterns in different subtypes.   The comparison was performed by the log-rank test. OS, overall survival; BP,   bisphosphonate; AE, adverse event.
<strong>Supplementary   Table 2 -</strong> Safety and efficacy of   bisphosphonate therapy
Characteristics of   patients between regular and irregular BP treatment groups. The Kaplan-Meier curves for SRE-free   survivals of patients with regular and irregular therapy modes stratified by   different OS and infusion times. Statistical analysis was performed using the   log-rank test. OS, overall survival; BP, bisphosphonate; SRE,   skeletal-related event.